Cargando…
Induction therapy in recurrent head and neck squamous cell carcinoma: is it time to consider response as a determinant of treatment selection?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174831/ https://www.ncbi.nlm.nih.gov/pubmed/37180661 http://dx.doi.org/10.21037/tcr-23-59 |
| _version_ | 1785040119070195712 |
|---|---|
| author | Tasoulas, Jason Sheth, Siddharth |
| author_facet | Tasoulas, Jason Sheth, Siddharth |
| author_sort | Tasoulas, Jason |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10174831 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101748312023-05-12 Induction therapy in recurrent head and neck squamous cell carcinoma: is it time to consider response as a determinant of treatment selection? Tasoulas, Jason Sheth, Siddharth Transl Cancer Res Editorial Commentary AME Publishing Company 2023-03-23 2023-04-28 /pmc/articles/PMC10174831/ /pubmed/37180661 http://dx.doi.org/10.21037/tcr-23-59 Text en 2023 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Tasoulas, Jason Sheth, Siddharth Induction therapy in recurrent head and neck squamous cell carcinoma: is it time to consider response as a determinant of treatment selection? |
| title | Induction therapy in recurrent head and neck squamous cell carcinoma: is it time to consider response as a determinant of treatment selection? |
| title_full | Induction therapy in recurrent head and neck squamous cell carcinoma: is it time to consider response as a determinant of treatment selection? |
| title_fullStr | Induction therapy in recurrent head and neck squamous cell carcinoma: is it time to consider response as a determinant of treatment selection? |
| title_full_unstemmed | Induction therapy in recurrent head and neck squamous cell carcinoma: is it time to consider response as a determinant of treatment selection? |
| title_short | Induction therapy in recurrent head and neck squamous cell carcinoma: is it time to consider response as a determinant of treatment selection? |
| title_sort | induction therapy in recurrent head and neck squamous cell carcinoma: is it time to consider response as a determinant of treatment selection? |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174831/ https://www.ncbi.nlm.nih.gov/pubmed/37180661 http://dx.doi.org/10.21037/tcr-23-59 |
| work_keys_str_mv | AT tasoulasjason inductiontherapyinrecurrentheadandnecksquamouscellcarcinomaisittimetoconsiderresponseasadeterminantoftreatmentselection AT shethsiddharth inductiontherapyinrecurrentheadandnecksquamouscellcarcinomaisittimetoconsiderresponseasadeterminantoftreatmentselection |